SCHEMBL14280209

SCHEMBL14280209

Cc1ccc(-n2c(-c3ccccc3)cc(-c3ccccc3)c2C)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 5/20 0.55
CYP2C9 P11712 1/20 0.55
MAPK1 P28482 1/20 0.50
PLK1 P53350 1/20 0.47
TSHR P16473 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.43
THRB P10828 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 2/20 0.43
HPGD P15428 2/20 0.43
PPARG P37231 1/20 0.43
NCOA2 Q15596 1/20 0.43
NCOA1 Q15788 1/20 0.43
GAA P10253 1/20 0.43
LMNA P02545 4/20 0.41
CHRNA7 P36544 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10205950 0.91 PLK1 (0.54) HTTCYP2C9PLK1TSHRNPC1
SCHEMBL14280204 0.85 MAPT (0.46) HTTCYP2C9MAPK1PLK1TSHR
SCHEMBL438258 0.83 ALDH1A1 (0.62) HTTMAPK1PLK1SMN1; SMN2NPC1
SCHEMBL15694845 0.80 HTT (0.59) HTTCYP2C9MAPK1PLK1TSHR
SCHEMBL5010875 0.77 MAPK1 (0.59) HTTCYP2C9MAPK1SMN1; SMN2NPC1
SCHEMBL12345589 0.76 HTT (0.59) HTTCYP2C9MAPK1PLK1TSHR
SCHEMBL435644 0.75 RXRA (0.58) MAPK1PLK1SMN1; SMN2THRBALDH1A1
SCHEMBL5012548 0.75 CYP2C9 (0.54) HTTCYP2C9MAPK1PLK1TSHR
SCHEMBL13997263 0.75 HTT (0.54) HTTCYP2C9MAPK1PLK1TSHR
SCHEMBL5605369 0.75 APP (0.64) HTTCYP2C9MAPK1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008031034-A2 THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS MYRIAD GENETICS, INC. (US) 2008-03-13 WO disclosed